INTRODUCTION
Endothelin-1, a 21-residue vasoactive peptide originally isolated from vascular endothelium, is the most potent vasoconstrictor known to date (1) . Endothelin-1 and its isopeptides, endothelin-2 and endothelin-3, were subsequently found to play diverse physiological roles (2) . These effects are mediated by two distinct subtypes of G protein-coupled heptahelical receptors, ET A and ET B , expressed in a wide variety of tissues (3, 4) . Endothelin-1 is also known to be a potent mitogen: it stimulates proliferation of vascular (5) and nonvascular cells (6, 7) , activates mitogen-activated protein (MAP) kinase (8, 9) , induces expression of immediate early response genes (c-myc, c-fos, erg-1, etc.), and functions as an autocrine/paracrine growth factor for certain tumor cell lines (10) . Disruption of the endothelin-1 gene in mice results in fatal craniofacial malformations in tissues derived from the first branchial arch, indicating an essential role of endothelin-1 in the development of neural crest-derived tissues (11) .
The c-myc protooncogene belongs to the family of immediate early growth response genes, and is believed to participate in regulating the cascade of events that follow mitogenic stimulation of quiescent cells. The c-myc gene is expressed at a low constitutive level in most growing cells, at elevated levels in a variety of tumors, and is down-regulated in both quiescent and differentiated cells. Numerous lines of evidence implicate c-Myc in the regulation of proliferation, mitogenesis, differentiation, and programmed cell death (12) (13) (14) . However, much of our understanding of c-Myc function derives from studies of cells overexpressing the c-myc gene. For example, fibroblasts expressing high levels of c-Myc protein are more prone to apoptosis upon serum deprivation (14) , and this effect can be suppressed by two cytokines, PDGF and insulin-like growth factor I (IGF-I) (15) . Ras triggers both a phosphatidylinositol-3 (PI3) kinase-dependent antiapoptotic pathway and a Raf-MAP kinase proapoptotic pathway in fibroblasts overexpressing c-Myc (16) . Recent studies have suggested a role for a balance between MAP kinase and stress-activated JUN kinase-p38 pathways in determining apoptotic frequency of PC12 pheochromocytoma cells (17) , and a role for PI3 kinase in the prevention of apoptosis by nerve growth factor (18) . However, functional Max protein, the dimerization partner of Myc, is not expressed in PC12 cells because of the synthesis of a mutant 0888-8809/97/$3.00/0 Molecular Endocrinology Copyright © 1997 by The Endocrine Society max transcript (19) . To investigate the consequences of physiological c-myc expression, we have previously disrupted one c-myc gene copy in a diploid fibroblast cell line (20) . This subtle perturbation of c-myc expression resulted in slower growth rates, lengthening of the G 0 -to-S cell cycle transition, and modulation of cyclin E expression (21) .
In the present report, we have confirmed that apoptosis observed in fibroblasts with diploid c-myc is also a c-Myc-dependent process and further show a striking role for the endothelin-1 peptide acting through the ET A receptor as a potent apoptosis survival factor via MAP kinase activation. Our data imply that both circulating as well as local endothelin-1 may act on fibroblasts to protect them from apoptotic death under physiological conditions.
RESULTS

Serum Deprivation Induces Apoptosis in Diploid Fibroblasts via c-Myc-Dependent Process
We used four isogenic fibroblast cell lines (TGR-1, HET15, HET16, and M5) derived from Rat-1 cell line: TGR-1 is a nontransformed, diploid rat fibroblast cell line (22) ; HET15 and HET16 are two independent TGR-1 derivatives with one endogenous c-myc copy knocked out by gene targeting, and express 50% of normal diploid c-Myc levels (20) . The M5 cell line is HET15 infected with a retrovirus vector expressing the c-Myc-Estrogen Receptor (Myc-ER) chimeric protein (23, 24) . Myc-ER was functionally activated by the addition of 10 nM ␤-estradiol to the medium. When rendered quiescent by serum deprivation, fibroblast cultures always contain a fraction of floating cells, which displayed characteristic features of apoptosis, such as condensed chromatin and subnuclear bodies, and electrophoresis of DNA samples showed a nucleosomal ladder (Fig. 1B) . Although the fraction of cells susceptible to apoptosis is dependent on the density of the cultures, HET15 and HET16 cultures always displayed fewer apoptotic cells (13.9 Ϯ 2.3% and 16.9 Ϯ 2.7% of TGR-1 in exponentially growing cultures, respectively) than TGR-1 (Fig. 1A) . M5 cells, undergoing a low level of apoptosis in the absence of ␤-estradiol, showed massive apoptosis of rapid onset upon serum withdrawal when pretreated with 100 nM ␤-estradiol, and approximately 70% of cell death when pretreated with 10 nM ␤-estradiol for 48 h (ϳ2.7-fold greater than TGR-1) (Fig. 1A) . Electrophoresis of DNA samples extracted from M5 pretreated with ␤-estradiol showed a marked enhancement of nucleosomal laddering (Fig. 1B) . Flow cytometric analysis revealed that the number of TGR-1 with subdiploid DNA content increased after serum deprivation (Figs. 1B and 5C): 0.2% before serum withdrawal, 6.0% after 4 h, and 17.0% after 24 h. Adherent TGR-1 cells in serum-starved culture were stained with antibody against single-stranded DNA. Immunohistochemically positive cells coincided with those showing cellular and nuclear fragments ( Fig. 2A) . Taken together, the results indicate that serum deprivation induces c-Mycdependent apoptosis in fibroblasts, which is manifested as floating dead cells.
Endothelin-1 Suppresses Apoptosis via the ET A Receptor
Treatment with endothelin-1 significantly and dosedependently (10
Ϫ11
-10 Ϫ6 M) reduced the fraction of TGR-1 cells undergoing apoptosis (Fig. 3A) . Apoptosis of M5 elicited by 10 nM ␤-estradiol was also significantly inhibited by addition of endothelin-1 in concentrations lower (10 Ϫ13 -10 Ϫ11 M) than those for TGR-1 (Fig. 3A) . We therefore conclude that endothelin-1 blocks c-Myc-dependent apoptosis in rat fibroblasts, thus functioning as a survival factor.
To determine whether the potencies of endothelin-1 necessary to induce cell division and to antagonize apoptosis correlate with each other, we examined endothelin-1-mediated mitogenesis. Endothelin-1 dose- respectively. The maximal response of HET15 cells was about two-thirds that of TGR-1. Endothelin-1-induced mitogenesis was not observed at lower concentrations (10 Ϫ13 -10 Ϫ9 M), at which concentrations a significant apoptosis protection was induced.
To characterize the endothelin-1 receptor subtype mediating the protective effect, binding studies using (25) (Fig. 4B ), whereas ET B mRNA was not detectable in any of the cell lines.
To determine whether inhibition of apoptosis by endothelin-1 in fibroblast cell lines is indeed mediated by the ET A receptor, we examined whether endothelin receptor antagonists can abrogate the protective effect of endothelin-1 in TGR-1. The ET A receptor antagonist, BQ123, completely blocked the protective effect induced by endothelin-1, whereas ET B receptor antagonist, BQ788, did not show a significant effect (Fig. 4C ). Neither BQ123 nor BQ788 added alone affected the apoptotic frequency of TGR-1. Likewise, BQ123, but not BQ788, abrogated the survival effect provoked by endothelin-1 on M5 (Fig. 4C) . The above data are complemented by the immunohistochemical study shown in Fig. 2 . TGR-1 cells were changed into serum-free medium, and all adherent cells after 24 h were stained simultaneously with antibody against single-stranded DNA and with hematoxylin. Immunohistochemically positive cells coincided with those show- ing cellular and nuclear fragments. Addition of endothelin-1 markedly reduced the number of adherent apoptotic cells (Fig. 2B) . BQ123 abolished apoptosis protection by endothelin-1 (Fig. 2C) , whereas BQ788 did not affect the endothelin-1-induced apoptosis inhibition (Fig. 2D) . These results indicate a role for endothelin-1 as a survival factor from c-Mycdependent apoptosis and show that this effect is mediated by the ET A receptor.
ET A Receptor-Mediated Apoptosis Protection Acts via MAP Kinase Activation
We searched for intracellular signal(s) essential for the endothelin-1-induced cell survival by a pharmacological approach. Pretreatment of TGR-1 with the following compounds neither affected basal cell viability nor antagonized the cell survival effect of endothelin-1 (data not shown): PI3 kinase inhibitors, wortmannin ( all four cell lines. Although this effect was completely blocked by BQ123, it was not elicited at lower concentrations (10 Ϫ13 to 10 Ϫ9 M) of endothelin-1, suggesting that ET A receptor-mediated activation of phospholipase C is not involved in the endothelin-1-induced cell survival. We considered the possibility that, at these low concentrations, endothelin-1 may stimulate the production of certain growth factors, such as IGF-I and PDGF, which in turn could inhibit c-Myc-dependent apoptosis by a paracrine mechanism. However, the cell lines released IGF-I and PDGF-B at far lower concentrations than those reported to suppress apoptosis as determined by RIAs, and addition of the antibodies for IGF-I or PDGF-BB did not affect the protective effect induced by endothelin-1 (data not shown). These data argue against an intermediate role of these growth factors for the cell survival effect of endothelin-1. We examined whether the MAP kinase pathway is involved in the endothelin-1-induced cell survival. Pretreatment of TGR-1 with PD98059 (5 ϫ 10 Ϫ5 M), a specific inhibitor of MAP kinase kinase (26) (27) (28) , did not affect cell viability, but blocked the apoptosis protection of endothelin-1 (Fig. 5) . Treatment of the cells with a liposome-encapsulated antisense oligonucleotide directed against the translation initiation sites of the p42 and p44 rat MAP kinase isoform mRNAs antagonized the cell survival effect of endothelin-1, whereas random and sense oligonucleotides were without effect (Fig. 6A) . Furthermore, transfection of TGR-1 cells with a dominant-interfering form of MAP kinase kinase 1 (MAPKK1 S222A) prevented the apoptosis survival activity of endothelin-1 (Fig. 6B) . Transfection of TGR-1 cells with a constitutively activated form of MAP kinase kinase 1 (MAPKK1 S218D/S222A) prevented apoptosis induced by serum deprivation (data not shown). These results indicate a central role for the MAP kinase pathway in mediating cell survival by endothelin-1.
Removal of serum for 2 h resulted in a marked reduction (less than 5% of basal levels) in MAP kinase activities (Fig. 7A) . Addition of endothelin-1 (10 Ϫ7 M) to quiescent TGR-1 stimulated MAP kinase activity, which peaked at 5 min and declined after 60 min (Fig.  7B) . These results were confirmed by phosphorylation 
DISCUSSION
It is well documented that increased expression of c-Myc can trigger apoptosis in several experimental systems (29, 30) . We have observed this phenomenon using fibroblast cell lines that stably overexpress a Myc-ER chimeric protein (23, 24) , whose activity is dependent on the presence of exogenous ␤-estradiol. One potential problem involving the use of the Myc-ER fusion protein is its supraphysiological expression level. To address the question whether apoptosis observed in cells expressing physiological c-Myc levels is also a c-Myc-dependent process, we used two independent heterozygous cell lines (HET15 and HET16) obtained by gene targeting of one endogenous c-myc gene copy (20) . Heterozygous cells are genetically stable, free from discernible additional genetic changes, and are isogenic with the wild-type parental cell line (TGR-1) (20, 21) . Thus, any phenotypic changes that the two independent cell lines display, and which are reversed by introducing a c-myc transgene, are considered due solely to changes in c-myc expression. In the present study, both heterozygous cell lines always showed low levels of apoptosis after serum starvation, and restoration of c-Myc expression markedly increased the frequency of apoptosis. Taken together, these data indicate that apoptosis observed in the parental diploid TGR-1 cells is a c-Myc-dependent process.
c-Myc-dependent apoptotic processes require p53 expression (31), while apoptosis induced by DNA damage is antagonized by bcl-2 expression via a p53-independent mechanism (32) . In addition to Bcl-2, certain growth factors, such as IGF-I, insulin, and PDGF, have been demonstrated to rescue cells, at least partially, from c-Myc-induced apoptosis (15) . Since the potency of these growth factors to induce cell division and to antagonize apoptosis do not correlate, it has been suggested that these peptides can act as distinct cell survival factors. In this communication, we present evidence that endothelin-1, a potent vasoconstrictor and mitogen originally identified in vascular endothelial cells, can also be categorized as an apoptosis survival factor. The present study shows that endothelin-1 can antagonize apoptosis and promote cell survival at concentrations (10 Ϫ13 -10 Ϫ9 M) distinctly below those required for stimulation of DNA synthesis (10
Since fibroblasts do not produce and secrete endothelin-1, their survival in an organismal context could be mediated by endothelin-1 secreted by other cells. It should be emphasized that the minimum effective concentrations to induce apoptotic protection in TGR-1 and M5 cells by endothelin-1 are 10 Ϫ11 M and 10 Ϫ13 M, respectively. These concentrations are comparable with those (ϳ10 Ϫ12 M) of circulating endothelin-1 in animals and humans (33) , which are also distinctly below those required for stimulation of DNA synthesis (10 Ϫ9 -10 Ϫ7 M). In addition, the concentrations of endothelin-1 are lower than those of other growth factors and cytokines known to block apoptosis (IGF-I, 100 ng/ml; insulin, 5 g/ml; PDGF, 10 ng/ml) (15) .
Since endothelin-1-induced cell survival occurs in cells expressing physiological c-Myc levels, our data imply that endogenous endothelin-1 may also serve as a survival factor in vivo. In fact, in primary rat endothelial cells, endogenous endothelin-1 secretion protects the cells from apoptotic death in an autocrine/ paracrine fashion via the ET B receptor (34) , while in vascular smooth muscle cells, low doses of endothelin-1 suppress apoptosis induced by serum deprivation via the ET A receptor (our unpublished observation). Furthermore, endothelin-receptor antagonists have been demonstrated to prevent ventricular remodeling (35) and to suppress postangioplastyinduced neointima formation in rats (36) . Taken together, these results suggest a physiological significance of endothelin-1 as an apoptotic survival factor. The endothelin peptides family (endothelin-1, endothelin-2, and endothelin-3) mediate their diverse effects through two distinct subtypes of G protein-coupled heptahelical receptors, termed ET A and ET B (3, 4) . The ET A receptor is selective for endothelin-1 and endothelin-2, whereas the ET B receptor does not distinguish between isopeptides. Vascular smooth muscle cells mainly express ET A receptors that mediate contraction, while vascular endothelium expresses ET B receptors, which are involved in vasodilation via generation of nitric oxide (3, 4, 37) . Both receptor subtypes mediate the activation of MAP kinase (8, 9, 38) and are functionally coupled to phospholipase C to induce phosphoinositide breakdown (39) . In the present study, binding studies and Northern hybridization revealed that rat fibroblast cell lines under investigation express the ET A receptor, but not the ET B receptor. The protective effects of endothelin-1 from c-Myc-induced apoptosis were clearly mediated via the ET A receptor, as evidenced by the fact that the ET A receptor antagonist (BQ123), but not ET B receptor antagonist (BQ788), completely blocked the survival effect.
Our present experiments have uncovered an intriguing role of ET A receptor-mediated MAP kinase pathway activation for cell survival. MAP kinase activation can inhibit induction of apoptosis in PC-12 cells deprived of nerve growth factor (17) , in ceramide-treated HL60 cells (40) , and in cerebellar neurons deprived of potassium (41) . Raf-1 activation has been shown to protect Rat-1 fibroblasts from c-Myc-induced apoptosis (42) , while a contrasting report suggests proapoptotic effects of a Raf-MAP kinase pathway (16) . In our system, neither the farnesyltransferase inhibitor, manumycin, nor PI3 kinase inhibitors, wortmannin and LY294002, had any effect on endothelin-1-mediated cell survival, while the activation of MAP kinase had clear antiapoptotic effects. However, it remains to be determined whether a complete abrogation of Ras activity, for example, using a dominant-defective Ras mutant, would influence the survival effect of endothelin-1.
In summary, using a panel of isogenic rat fibroblast cell lines, we demonstrate a novel role of endothelin-1 as an apoptosis survival factor. Both physiological c-myc expression, as well as unphysiologically high levels, caused apoptosis upon serum deprivation. The effect of endothelin-1 to block c-Myc-dependent apoptosis was mediated through ET A receptor via MAP kinase activation and was clearly distinct from its proliferative effect.
MATERIALS AND METHODS
Cell Culture
The established rat fibroblast cell lines (TGR-1, HET15, HET16, and M5) are derivatives of the Rat-1 cell line and cultured in DMEM supplemented with 10% calf serum, glutamine, penicillin, and streptomycin sulfate in a 5% CO 2 atmosphere at 37 C.
Reagents
Synthetic endothelin-1, synthetic endothelin-3, MG115, MG132, Ac-Tyr-Val-Ala-Asp-H, and Ac-Asp-Glu-Val-Asp-H were purchased from Peptide Institute, Inc. (Osaka, Japan); tyrphostin B42, U73122, GF109203X, genistein, herbimycin A, and ST638 were from Calbiochem-Novabiochem Intl. (La Jolla, CA); nicardipine and wortmannin were from SigmaAldrich (Tokyo, Japan). ET A receptor antagonist (BQ123) and ET B receptor antagonist (BQ788) were provided by Banyu Research Laboratory (Tsukuba, Japan); benizipine was from Kyowa Hakko Pharmaceuticals (Tokyo, Japan); SB203580 from SmithKline Beecham Pharmaceuticals (Philadelphia, PA).
Plasmids
The plasmid MAPKK1 S222A (kindly provided by Drs. Anne Brunet and Jacques Pouyssegur) is a dominant-interfering form of MAP kinase kinase 1 expressed from the SV40 early promoter, and the plasmid MAPKK1 S218D/S222D (kindly provided by Drs. Anne Brunet and Jacques Pouyssegur) is a constitutively activated form of MAP kinase kinase 1 (43) .
Cell Death Analysis
Exponentially growing cells in 24-well dishes were extensively washed and replaced with serum-free medium containing endothelin-1, and after 24 h floating cell numbers were determined with a Sysmex CDA-500 Autoanalyzer (Toa Medical Electronics, Kobe, Japan). To demonstrate nucleosome laddering, cellular fragmented DNAs were extracted from total cell cultures 4 h after serum starvation using NP-40 lysis, which eliminates intact chromatin (44) , and fractionated on 1.2% agarose gels. Flow cytometric analysis was performed using a FACS Calibur (Becton Dickinson, San Jose, CA) on cells stained with propidium iodide. For transfection of MAPKK1 S222A and MAPKK1 S218D/S222D plasmids (42), TGR-1 cells grown to 60% confluence in 10-cm plates were transfected with 5 g plasmid DNA by the transferrin receptor-mediated transfer method (45) for 16 h, incubated in 10% calf serum-DMEM for 48 h, serum-starved, and subjected to cell death analysis.
Immunohistochemical Staining for Single-Stranded DNA Adherent TGR-1 cells, serum-deprived and incubated with or without endothelin-1 (10 Ϫ7 M) in the presence or absence of BQ123 or BQ788 for 24 h, were fixed in 70% acetone and stained with rabbit polyclonal antibody raised against singlestranded DNA (46, 47) (dilution 1:500), as previously described (48) .
DNA Synthesis
Cells were serum-deprived for 24 h, incubated with or without endothelin-1 for 16 h, and pulsed with 0.5 Ci [ 3 H]thymidine (Amersham, Arlington Heights, IL) for 2 h. After incubation, cells were extensively washed with ice-cold 5% trichloroacetic acid, and radioactivity incorporated into cells was determined.
Binding Experiments
Cells were incubated at 37 C and 4 C for 2 h with 8.6 ϫ 10 Ϫ12
M [
125 I]endothelin-1 (specific activity 2000 Ci/mmol, Amersham) in the presence or absence of unlabeled endothelin-1, extensively washed, and solubilized with 1 N NaOH, and the cell-bound radioactivity was measured (10) . Specific binding was calculated as the total radioactivity bound minus nonspecific binding in the presence of excess (10 Ϫ6 M) unlabeled endothelin-1. The apparent dissociation constant (K d ) and maximal binding capacity (B max ) were calculated by Scatchard analysis of the binding data.
Northern Hybridization Analysis
RNA was extracted by the guanidinium thiocyanate method, as described (10) . Total RNA (15 g) was electrophoresed on formaldehyde-agarose gels. Blotting was onto MagnaGraph nylon membranes (Micron Separations, Inc., Westborough, MA). cDNA probes for rat ET A and ET B receptor genes and GAPDH genes were labeled with ␣-[ 32 P]dCTP using the random-priming method.
Oligodeoxynucleotides
An antisense oligodeoxyribonucleotide, a phosphorothioateprotected 17-mer directed against the initiation of translation site of rat p42 and p44 MAP kinase mRNA (5Ј-GCCGCCGC-CGCCGCCAT-3Ј), sense (5Ј-ATGGCGGCGGCGGCGGC-3Ј) and random (5Ј-CGCGCGCTCGCGCACCC-3Ј) oligonucleotides were synthesized and introduced into TGR-1 using transferrin receptor-mediated-transfer (45) . The efficiency was determined using FITC-conjugated oligonucleotides: at least 80% of total cells became transfected within 5 h of transfection, and the intensity of cellular fluorescence correlated well with the oligonucleotide concentration used (0.2-10 M).
MAP Kinase Activity
TGR-1 cells, incubated in the presence or absence of endothelin-1, were lysed and sonicated. After centrifugation at 25,000 ϫ g for 20 min, the supernatant was assayed for MAP kinase activity with an p42/p44 MAP kinase enzyme assay system using [␥- 
Statistical Analysis
Data are expressed as mean Ϯ SEM. Statistical analysis were performed by using ANOVAs for repeated measures.
